HealthFlex
×
  • About Us
    • Management
    • Family of Companies
    • History
    • Facilities
    • Humane Care Commitment
    •  Board of Directors
  • Services
    • Toxicology
    • Bioanalytical / Analytical Chemistry
    • Pharmacokinetics / Toxicokinetics
    • Formulation
    • Pharmacology
    • Agrochemicals and Commodity Chemicals
    • Medicinal Chemistry
    • Colony Maintenance
    • Ocular
  • Specialty Expertise
    • Respiratory
    • Infectious Disease
    • Gene Therapy
    • Neuroscience
    • Alternative Tobacco Products
    • Medical Countermeasures
  • COVID-19 Research
  • News
    • Publications
    • Blog
  • Careers
    • Benefits & Compensation
  • Contact
  • For Employees
Lovelace Biomedical Operations During the Coronavirus Pandemic

Lovelace Biomedical Operations During the Coronavirus Pandemic

March 20, 2020news

Our Contingency Plans and Working During the COVID-19 (Coronavirus) Outbreak

As many have companies have prepared and set in motion their own contingency plans during the Coronavirus pandemic, Senior Leadership and our Board of Directors have also actively set forth policy at Lovelace Biomedical.

Please be assured that we have put in safeguards and preventative measures at our own facilities, by using tactics such as social distancing, and allowing some employees to work from home, in order to maintain operations during this critical time. We are paying close attention to such agencies like the World Health Organization (WHO), and the Center for Disease Control (CDC), and are adhering to their guidance and suggestions.

After careful consideration, we have also decided to suspend outside visitation, so as to not affect the integrity of our current ongoing studies and our overall operations. We will continue to suspend visitation to our campus indefinitely. Thereafter, we will reassess the situation based on the guidance from the World Health Organization, and also the Center for Disease Control.

Like many others, we are also taking internal precautions by restricting our own employee travel, and are committed to communicating in other ways, including video conferencing. We are always available by phone, email, and other normal means of communication.

Thank you for your patience and understanding while we all navigate this challenging health crisis.

Recent News

  • Lovelace Biomedical to Present Webinar on Inhalation Toxicology for a Range of Drug Classes
  • Lovelace Biomedical Welcomes New Scientific Advisor and Infectious Disease Program Contributor
  • Published: Scientific paper from our Lung Cancer Program – The affects of e-liquid acquired from vaping
  • Webinar – Clinical and Translational Response to COVID-19
  • Lovelace Biomedical and National Jewish Health to Host Webinar; Clinical and Translational Response to COVID-19

For General needs and employment verification

(505) 348-9361

info@lrri.org

www.lovelacebiomedical.org

2425 Ridgecrest Dr. SE, Albuquerque, NM 87108-5127

For Business Development Needs

For Business Development Needs

(202) 819-5108

mmcmullen@lovelacebiomedical.org

www.lovelacebiomedical.org

2425 Ridgecrest Dr. SE, Albuquerque, NM 87108-5127

Quick Links

  • Home
  • About Us
  • History
  • Humane Care Commitment
  • Services
  • Specialty Expertise
  • News
  • Careers
  • Preclinical COVID-19 Research
  • Contact

Latest News

  • From Our Blog: PCR Development, it’s Uses, and Important Research at Lovelace Biomedical, with Bryan Gullick, PhD, Bioanalytical Research Scientist Jan 28

    Staff Spotlight: Bryan Gullick, PhD, Research Scientist Bryan, tell us about PCR in the development and conduct of...

  • Blog: Preclinical Drug Development for a Gene Therapy Product: No Cookie Cutter Route Jan 11

    Preclinical Drug Development for a Gene Therapy Product: No Cookie Cutter Route   Follow these critical steps...

Copyright © 2018 Lovelace Biomedical. All Rights Reserved.
Powered by J B Soft System, Chennai.